SCHEMBL15870509

SCHEMBL15870509

COc1ccc(-c2cncc(N[C@@H](CO)c3ccccc3)c2)cc1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CCNC P24863 2/20 0.60
▸ CDK8 P49336 2/20 0.60
▸ EGFR P00533 2/20 0.51
▸ MEN1 O00255 1/20 0.47
▸ KMT2A Q03164 1/20 0.47
▸ GPR88 Q9GZN0 1/20 0.46
▸ CYP11B1 P15538 1/20 0.46
▸ CYP11B2 P19099 1/20 0.46
▸ CTSA P10619 1/20 0.45
▸ CCNT1 O60563 1/20 0.45
▸ CDK9 P50750 1/20 0.45
▸ FGFR2 P21802 1/20 0.44
▸ FDPS P14324 2/20 0.44
▸ XDH P47989 1/20 0.44
▸ SLC22A12 Q96S37 1/20 0.44
▸ CDK2 P24941 2/20 0.44
▸ CDK7 P50613 1/20 0.44
▸ ALPL P05186 1/20 0.43
▸ ROCK2 O75116 4/20 0.43
▸ ROCK1 Q13464 3/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15864390 0.88 CCNC (0.58) CCNCCDK8EGFRCYP11B1CYP11B2
SCHEMBL15864387 0.88 CCNC (0.58) CCNCCDK8EGFRCYP11B1CYP11B2
SCHEMBL15870506 0.86 CCNC (0.64) CCNCCDK8CCNT1CDK9FGFR2
SCHEMBL15870565 0.85 CCNC (0.50) CCNCCDK8EGFRMEN1KMT2A
SCHEMBL15870581 0.85 CDK8 (0.57) CCNCCDK8EGFRCYP11B1CYP11B2
SCHEMBL15870534 0.84 CCNC (0.59) CCNCCDK8EGFRMEN1KMT2A
SCHEMBL15870552 0.84 CCNC (0.64) CCNCCDK8EGFRCCNT1CDK9
SCHEMBL15870508 0.84 CCNC (0.64) CCNCCDK8EGFRCCNT1CDK9
SCHEMBL15870515 0.84 CCNC (0.64) CCNCCDK8EGFRCCNT1CDK9
SCHEMBL15870531 0.83 CCNC (0.58) CCNCCDK8EGFRCCNT1CDK9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2014106606-A1 NOVE PHENYL/PYRIDINE SERIES SUBSTITUED BY HYDROXYETHYLAMINO FOR THE TREATMENT OF CANCER F. HOFFMANN-LA ROCHE AG (CH) 2014-07-10 — — WO disclosed
Send feedback